New combo therapy aims to stop liver cancer from coming back
Disease control
Recruiting now
This study tests whether giving a PD-1 inhibitor drug after microwave ablation can help prevent early-stage liver cancer from returning. About 200 adults with early liver cancer will receive the drug after their ablation procedure. The goal is to see if this combination improves …
Phase: NA • Sponsor: Chen Xiaoping • Aim: Disease control
Last updated May 04, 2026 16:24 UTC